|
Synonyms: Leukine®
sargramostim is an approved drug (FDA (1991))
Compound class:
Peptide or derivative
Comment: Sargramostim is recombinant human GM-CSF, produced in E.coli. Compared to the endogenous peptide sargramostim has a Arg>Leu substitution at residue 23.
|
Classification  |
|
| Compound class | Peptide or derivative |
| Approved drug? | Yes (FDA (1991)) |
| International Nonproprietary Names |
|
| INN number | INN |
| 6842 | sargramostim |
| Synonyms |
| Leukine® |
| Database Links |
|
| Specialist databases | |
| IMGT/mAb-DB | 709 |
| Other databases | |
| ChEMBL Ligand | CHEMBL1201670 |
| DrugBank Ligand | DB00020 |
| GtoPdb PubChem SID | 249565588 |
| Search PubMed clinical trials | sargramostim |
| Search PubMed titles | sargramostim |
| Search PubMed titles/abstracts | sargramostim |
| Wikipedia | Sargramostim |
